Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

NCT03859141 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2340

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Influenza

Interventions

BIOLOGICAL: Quadrivalent influenza vaccine
BIOLOGICAL: Quadrivalent influenza vaccine
BIOLOGICAL: Trivalent influenza vaccine (contains B/Victoria strain)
BIOLOGICAL: Trivalent influenza vaccine (contains B/Yamagata strain)

Sponsor

Sinovac Biotech Co., Ltd